Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15028484 | 0.84 | BMP1 (0.30) | — | |
| SCHEMBL27041677 | 0.79 | GGH (0.33) | — | |
| SCHEMBL27041682 | 0.79 | GGH (0.33) | — | |
| SCHEMBL15028483 | 0.77 | — | — | |
| SCHEMBL16271230 | 0.73 | TRPV1 (0.33) | — | |
| SCHEMBL17586046 | 0.73 | TRPV1 (0.33) | — | |
| SCHEMBL23747679 | 0.71 | CTSL (0.31) | CTSLCTSB | |
| SCHEMBL15728239 | 0.70 | — | — | |
| SCHEMBL10296038 | 0.70 | LMNA (0.42) | — | |
| SCHEMBL21661358 | 0.70 | SPHK1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160194391-A1 | ANTIBODY DERIVATIVES | ALLOZYNE, INC. | 2016-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160194391-A1 | ANTIBODY DERIVATIVES | IL23R, IL6, IL2 | CTSL 1362/4885CTSB 1220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.